Sang Youl Rhee, Kyung-Do Han, Hyemi Kwon, Se-Eun Park, Yong-Gyu Park, Yang-Hyun Kim, Soon-Jip Yoo, Eun-Jung Rhee, Won-Young Lee. Diabetes Care 2020
Times Cited: 22
Times Cited: 22
Times Cited
Times Co-cited
Similarity
Association between Parkinson's disease and diabetes: Data from NEDICES study.
E De Pablo-Fernandez, F Sierra-Hidalgo, J Benito-León, F Bermejo-Pareja. Acta Neurol Scand 2017
E De Pablo-Fernandez, F Sierra-Hidalgo, J Benito-León, F Bermejo-Pareja. Acta Neurol Scand 2017
27
Type 2 diabetes and the risk of Parkinson's disease.
Gang Hu, Pekka Jousilahti, Siamak Bidel, Riitta Antikainen, Jaakko Tuomilehto. Diabetes Care 2007
Gang Hu, Pekka Jousilahti, Siamak Bidel, Riitta Antikainen, Jaakko Tuomilehto. Diabetes Care 2007
27
Diabetes and risk of Parkinson's disease.
Qun Xu, Yikyung Park, Xuemei Huang, Albert Hollenbeck, Aaron Blair, Arthur Schatzkin, Honglei Chen. Diabetes Care 2011
Qun Xu, Yikyung Park, Xuemei Huang, Albert Hollenbeck, Aaron Blair, Arthur Schatzkin, Honglei Chen. Diabetes Care 2011
27
Reduced incidence of Parkinson's disease after dipeptidyl peptidase-4 inhibitors-A nationwide case-control study.
Per Svenningsson, Karin Wirdefeldt, Li Yin, Fang Fang, Ioanna Markaki, Suad Efendic, Jonas F Ludvigsson. Mov Disord 2016
Per Svenningsson, Karin Wirdefeldt, Li Yin, Fang Fang, Ioanna Markaki, Suad Efendic, Jonas F Ludvigsson. Mov Disord 2016
22
Diabetes and the risk of developing Parkinson's disease in Denmark.
Eva Schernhammer, Johnni Hansen, Kathrine Rugbjerg, Lene Wermuth, Beate Ritz. Diabetes Care 2011
Eva Schernhammer, Johnni Hansen, Kathrine Rugbjerg, Lene Wermuth, Beate Ritz. Diabetes Care 2011
22
Risk of Parkinson disease onset in patients with diabetes: a 9-year population-based cohort study with age and sex stratifications.
Yu Sun, Ya-Hui Chang, Hua-Fen Chen, Ying-Hwa Su, Hui-Fang Su, Chung-Yi Li. Diabetes Care 2012
Yu Sun, Ya-Hui Chang, Hua-Fen Chen, Ying-Hwa Su, Hui-Fang Su, Chung-Yi Li. Diabetes Care 2012
22
Diabetes and risk of Parkinson's disease: a systematic review and meta-analysis.
Emanuele Cereda, Michela Barichella, Carlo Pedrolli, Catherine Klersy, Erica Cassani, Riccardo Caccialanza, Gianni Pezzoli. Diabetes Care 2011
Emanuele Cereda, Michela Barichella, Carlo Pedrolli, Catherine Klersy, Erica Cassani, Riccardo Caccialanza, Gianni Pezzoli. Diabetes Care 2011
22
Exenatide once weekly versus placebo in Parkinson's disease: a randomised, double-blind, placebo-controlled trial.
Dilan Athauda, Kate Maclagan, Simon S Skene, Martha Bajwa-Joseph, Dawn Letchford, Kashfia Chowdhury, Steve Hibbert, Natalia Budnik, Luca Zampedri, John Dickson,[...]. Lancet 2017
Dilan Athauda, Kate Maclagan, Simon S Skene, Martha Bajwa-Joseph, Dawn Letchford, Kashfia Chowdhury, Steve Hibbert, Natalia Budnik, Luca Zampedri, John Dickson,[...]. Lancet 2017
22
Body mass index, diabetes, and the risk of Parkinson's disease.
Su-Min Jeong, Kyungdo Han, Dahye Kim, Sang Youl Rhee, Wooyoung Jang, Dong Wook Shin. Mov Disord 2020
Su-Min Jeong, Kyungdo Han, Dahye Kim, Sang Youl Rhee, Wooyoung Jang, Dong Wook Shin. Mov Disord 2020
22
Association between diabetes and subsequent Parkinson disease: A record-linkage cohort study.
Eduardo De Pablo-Fernandez, Raph Goldacre, Julia Pakpoor, Alastair J Noyce, Thomas T Warner. Neurology 2018
Eduardo De Pablo-Fernandez, Raph Goldacre, Julia Pakpoor, Alastair J Noyce, Thomas T Warner. Neurology 2018
18
Obesity, diabetes, and risk of Parkinson's disease.
Natalia Palacios, Xiang Gao, Marjorie L McCullough, Eric J Jacobs, Alpa V Patel, Tinisha Mayo, Michael A Schwarzschild, Alberto Ascherio. Mov Disord 2011
Natalia Palacios, Xiang Gao, Marjorie L McCullough, Eric J Jacobs, Alpa V Patel, Tinisha Mayo, Michael A Schwarzschild, Alberto Ascherio. Mov Disord 2011
18
Exenatide and the treatment of patients with Parkinson's disease.
Iciar Aviles-Olmos, John Dickson, Zinovia Kefalopoulou, Atbin Djamshidian, Peter Ell, Therese Soderlund, Peter Whitton, Richard Wyse, Tom Isaacs, Andrew Lees,[...]. J Clin Invest 2013
Iciar Aviles-Olmos, John Dickson, Zinovia Kefalopoulou, Atbin Djamshidian, Peter Ell, Therese Soderlund, Peter Whitton, Richard Wyse, Tom Isaacs, Andrew Lees,[...]. J Clin Invest 2013
18
Risk of Parkinson Disease in Diabetes Mellitus: An Updated Meta-Analysis of Population-Based Cohort Studies.
Xuejing Yue, Hehua Li, Haiqing Yan, Ping Zhang, Li Chang, Tong Li. Medicine (Baltimore) 2016
Xuejing Yue, Hehua Li, Haiqing Yan, Ping Zhang, Li Chang, Tong Li. Medicine (Baltimore) 2016
18
Prospective cohort study of type 2 diabetes and the risk of Parkinson's disease.
Jane A Driver, Ashley Smith, Julie E Buring, J Michael Gaziano, Tobias Kurth, Giancarlo Logroscino. Diabetes Care 2008
Jane A Driver, Ashley Smith, Julie E Buring, J Michael Gaziano, Tobias Kurth, Giancarlo Logroscino. Diabetes Care 2008
13
Association Between Diabetic Retinopathy and Parkinson Disease: The Korean National Health Insurance Service Database.
Seung Eun Lee, Kyungdo Han, Ji Yeon Baek, Kyung Soo Ko, Ki-Up Lee, Eun Hee Koh. J Clin Endocrinol Metab 2018
Seung Eun Lee, Kyungdo Han, Ji Yeon Baek, Kyung Soo Ko, Ki-Up Lee, Eun Hee Koh. J Clin Endocrinol Metab 2018
27
Insulin resistance and Parkinson's disease: A new target for disease modification?
D Athauda, T Foltynie. Prog Neurobiol 2016
D Athauda, T Foltynie. Prog Neurobiol 2016
13
Analysis of the Relationship between Type II Diabetes Mellitus and Parkinson's Disease: A Systematic Review.
Fauze Camargo Maluf, David Feder, Alzira Alves de Siqueira Carvalho. Parkinsons Dis 2019
Fauze Camargo Maluf, David Feder, Alzira Alves de Siqueira Carvalho. Parkinsons Dis 2019
14
Korean National Health Insurance Database.
Dong Wook Shin, BeLong Cho, Eliseo Guallar. JAMA Intern Med 2016
Dong Wook Shin, BeLong Cho, Eliseo Guallar. JAMA Intern Med 2016
13
Association between metformin and neurodegenerative diseases of observational studies: systematic review and meta-analysis.
Fan Ping, Ning Jiang, Yuxiu Li. BMJ Open Diabetes Res Care 2020
Fan Ping, Ning Jiang, Yuxiu Li. BMJ Open Diabetes Res Care 2020
15
Glitazone use associated with reduced risk of Parkinson's disease.
Brage Brakedal, Irene Flønes, Simone F Reiter, Øivind Torkildsen, Christian Dölle, Jörg Assmus, Kristoffer Haugarvoll, Charalampos Tzoulis. Mov Disord 2017
Brage Brakedal, Irene Flønes, Simone F Reiter, Øivind Torkildsen, Christian Dölle, Jörg Assmus, Kristoffer Haugarvoll, Charalampos Tzoulis. Mov Disord 2017
13
Neuroprotective effect of glucagon-like peptide-1 receptor agonist is independent of glycaemia normalization in type two diabetic rats.
Irina Filchenko, Anna Simanenkova, Svetlana Chefu, Maria Kolpakova, Timur Vlasov. Diab Vasc Dis Res 2018
Irina Filchenko, Anna Simanenkova, Svetlana Chefu, Maria Kolpakova, Timur Vlasov. Diab Vasc Dis Res 2018
20
Insulin Resistance Promotes Parkinson's Disease through Aberrant Expression of α-Synuclein, Mitochondrial Dysfunction, and Deregulation of the Polo-Like Kinase 2 Signaling.
Chien-Tai Hong, Kai-Yun Chen, Weu Wang, Jing-Yuan Chiu, Dean Wu, Tsu-Yi Chao, Chaur-Jong Hu, Kai-Yin David Chau, Oluwaseun Adebayo Bamodu. Cells 2020
Chien-Tai Hong, Kai-Yun Chen, Weu Wang, Jing-Yuan Chiu, Dean Wu, Tsu-Yi Chao, Chaur-Jong Hu, Kai-Yin David Chau, Oluwaseun Adebayo Bamodu. Cells 2020
13
Metformin lowers α-synuclein phosphorylation and upregulates neurotrophic factor in the MPTP mouse model of Parkinson's disease.
Nikita Katila, Sunil Bhurtel, Sina Shadfar, Sunil Srivastav, Sabita Neupane, Uttam Ojha, Gil-Saeng Jeong, Dong-Young Choi. Neuropharmacology 2017
Nikita Katila, Sunil Bhurtel, Sina Shadfar, Sunil Srivastav, Sabita Neupane, Uttam Ojha, Gil-Saeng Jeong, Dong-Young Choi. Neuropharmacology 2017
13
Metformin regulates astrocyte reactivity in Parkinson's disease and normal aging.
Young-Kyoung Ryu, Jun Go, Hye-Yeon Park, Young-Keun Choi, Yun Jeong Seo, Jung Hyeon Choi, Myungchull Rhee, Tae Geol Lee, Chul-Ho Lee, Kyoung-Shim Kim. Neuropharmacology 2020
Young-Kyoung Ryu, Jun Go, Hye-Yeon Park, Young-Keun Choi, Yun Jeong Seo, Jung Hyeon Choi, Myungchull Rhee, Tae Geol Lee, Chul-Ho Lee, Kyoung-Shim Kim. Neuropharmacology 2020
15
Diabetes medications and risk of Parkinson's disease: a cohort study of patients with diabetes.
Ruth Brauer, Li Wei, Tiantian Ma, Dilan Athauda, Christine Girges, Nirosen Vijiaratnam, Grace Auld, Cate Whittlesea, Ian Wong, Tom Foltynie. Brain 2020
Ruth Brauer, Li Wei, Tiantian Ma, Dilan Athauda, Christine Girges, Nirosen Vijiaratnam, Grace Auld, Cate Whittlesea, Ian Wong, Tom Foltynie. Brain 2020
13
Insulin resistance impairs nigrostriatal dopamine function.
J K Morris, G L Bomhoff, B K Gorres, V A Davis, J Kim, P-P Lee, W M Brooks, G A Gerhardt, P C Geiger, J A Stanford. Exp Neurol 2011
J K Morris, G L Bomhoff, B K Gorres, V A Davis, J Kim, P-P Lee, W M Brooks, G A Gerhardt, P C Geiger, J A Stanford. Exp Neurol 2011
13
Global, regional, and national burden of Parkinson's disease, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016.
. Lancet Neurol 2018
. Lancet Neurol 2018
13
Clinical features of Parkinson disease when onset of diabetes came first: A case-control study.
E Cereda, M Barichella, E Cassani, R Caccialanza, G Pezzoli. Neurology 2012
E Cereda, M Barichella, E Cassani, R Caccialanza, G Pezzoli. Neurology 2012
13
Semaglutide is Neuroprotective and Reduces α-Synuclein Levels in the Chronic MPTP Mouse Model of Parkinson's Disease.
Liping Zhang, LingYu Zhang, Lin Li, Christian Hölscher. J Parkinsons Dis 2019
Liping Zhang, LingYu Zhang, Lin Li, Christian Hölscher. J Parkinsons Dis 2019
13
Glucagon-like peptide-1/glucose-dependent insulinotropic polypeptide dual receptor agonist DA-CH5 is superior to exendin-4 in protecting neurons in the 6-hydroxydopamine rat Parkinson model.
Ling-Yu Zhang, Qian-Qian Jin, Christian Hölscher, Lin Li. Neural Regen Res 2021
Ling-Yu Zhang, Qian-Qian Jin, Christian Hölscher, Lin Li. Neural Regen Res 2021
33
Diabetes Mellitus as a Risk Factor for Parkinson's Disease: a Molecular Point of View.
Alice Biosa, Tiago F Outeiro, Luigi Bubacco, Marco Bisaglia. Mol Neurobiol 2018
Alice Biosa, Tiago F Outeiro, Luigi Bubacco, Marco Bisaglia. Mol Neurobiol 2018
13
D-Ala2-GIP-glu-PAL is neuroprotective in a chronic Parkinson's disease mouse model and increases BNDF expression while reducing neuroinflammation and lipid peroxidation.
Yanwei Li, WeiZhen Liu, Lin Li, Christian Hölscher. Eur J Pharmacol 2017
Yanwei Li, WeiZhen Liu, Lin Li, Christian Hölscher. Eur J Pharmacol 2017
13
Neuroprotective effects of lixisenatide and liraglutide in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine mouse model of Parkinson's disease.
W Liu, J Jalewa, M Sharma, G Li, L Li, C Hölscher. Neuroscience 2015
W Liu, J Jalewa, M Sharma, G Li, L Li, C Hölscher. Neuroscience 2015
13
A novel GLP-1/GIP dual agonist is more effective than liraglutide in reducing inflammation and enhancing GDNF release in the MPTP mouse model of Parkinson's disease.
Ziyue Yuan, Dongfang Li, Peng Feng, Guofang Xue, Chenhui Ji, Guanglai Li, Christian Hölscher. Eur J Pharmacol 2017
Ziyue Yuan, Dongfang Li, Peng Feng, Guofang Xue, Chenhui Ji, Guanglai Li, Christian Hölscher. Eur J Pharmacol 2017
13
Dynamic changes in pro- and anti-inflammatory cytokines in microglia after PPAR-γ agonist neuroprotective treatment in the MPTPp mouse model of progressive Parkinson's disease.
Augusta Pisanu, Daniela Lecca, Giovanna Mulas, Jadwiga Wardas, Gabriella Simbula, Saturnino Spiga, Anna R Carta. Neurobiol Dis 2014
Augusta Pisanu, Daniela Lecca, Giovanna Mulas, Jadwiga Wardas, Gabriella Simbula, Saturnino Spiga, Anna R Carta. Neurobiol Dis 2014
13
Motor and cognitive advantages persist 12 months after exenatide exposure in Parkinson's disease.
Iciar Aviles-Olmos, John Dickson, Zinovia Kefalopoulou, Atbin Djamshidian, Joshua Kahan, Peter Ell, Peter Whitton, Richard Wyse, Tom Isaacs, Andrew Lees,[...]. J Parkinsons Dis 2014
Iciar Aviles-Olmos, John Dickson, Zinovia Kefalopoulou, Atbin Djamshidian, Joshua Kahan, Peter Ell, Peter Whitton, Richard Wyse, Tom Isaacs, Andrew Lees,[...]. J Parkinsons Dis 2014
13
Utility of Neuronal-Derived Exosomes to Examine Molecular Mechanisms That Affect Motor Function in Patients With Parkinson Disease: A Secondary Analysis of the Exenatide-PD Trial.
Dilan Athauda, Seema Gulyani, Hanuma Kumar Karnati, Yazhou Li, David Tweedie, Maja Mustapic, Sahil Chawla, Kashfia Chowdhury, Simon S Skene, Nigel H Greig,[...]. JAMA Neurol 2019
Dilan Athauda, Seema Gulyani, Hanuma Kumar Karnati, Yazhou Li, David Tweedie, Maja Mustapic, Sahil Chawla, Kashfia Chowdhury, Simon S Skene, Nigel H Greig,[...]. JAMA Neurol 2019
13
Pioglitazone in early Parkinson's disease: a phase 2, multicentre, double-blind, randomised trial.
. Lancet Neurol 2015
. Lancet Neurol 2015
13
GLP-1 receptor stimulation preserves primary cortical and dopaminergic neurons in cellular and rodent models of stroke and Parkinsonism.
Yazhou Li, TracyAnn Perry, Mark S Kindy, Brandon K Harvey, David Tweedie, Harold W Holloway, Kathleen Powers, Hui Shen, Josephine M Egan, Kumar Sambamurti,[...]. Proc Natl Acad Sci U S A 2009
Yazhou Li, TracyAnn Perry, Mark S Kindy, Brandon K Harvey, David Tweedie, Harold W Holloway, Kathleen Powers, Hui Shen, Josephine M Egan, Kumar Sambamurti,[...]. Proc Natl Acad Sci U S A 2009
13
Glycation potentiates α-synuclein-associated neurodegeneration in synucleinopathies.
Hugo Vicente Miranda, Éva M Szego, Luís M A Oliveira, Carlo Breda, Ekrem Darendelioglu, Rita M de Oliveira, Diana G Ferreira, Marcos A Gomes, Ruth Rott, Márcia Oliveira,[...]. Brain 2017
Hugo Vicente Miranda, Éva M Szego, Luís M A Oliveira, Carlo Breda, Ekrem Darendelioglu, Rita M de Oliveira, Diana G Ferreira, Marcos A Gomes, Ruth Rott, Márcia Oliveira,[...]. Brain 2017
13
Peptide hormone exendin-4 stimulates subventricular zone neurogenesis in the adult rodent brain and induces recovery in an animal model of Parkinson's disease.
Göran Bertilsson, Cesare Patrone, Olof Zachrisson, Annica Andersson, Karin Dannaeus, Jessica Heidrich, Jarkko Kortesmaa, Alex Mercer, Elisabet Nielsen, Harriet Rönnholm,[...]. J Neurosci Res 2008
Göran Bertilsson, Cesare Patrone, Olof Zachrisson, Annica Andersson, Karin Dannaeus, Jessica Heidrich, Jarkko Kortesmaa, Alex Mercer, Elisabet Nielsen, Harriet Rönnholm,[...]. J Neurosci Res 2008
13
Thiazolidinedione use is associated with reduced risk of Parkinson's disease in patients with diabetes: a meta-analysis of real-world evidence.
Salman Hussain, Ambrish Singh, Harveen Baxi, Bruce Taylor, John Burgess, Benny Antony. Neurol Sci 2020
Salman Hussain, Ambrish Singh, Harveen Baxi, Bruce Taylor, John Burgess, Benny Antony. Neurol Sci 2020
37
Diabetes, smoking, and other medical conditions in relation to Parkinson's disease risk.
Karen M Powers, Terri Smith-Weller, Gary M Franklin, W T Longstreth, Phillip D Swanson, Harvey Checkoway. Parkinsonism Relat Disord 2006
Karen M Powers, Terri Smith-Weller, Gary M Franklin, W T Longstreth, Phillip D Swanson, Harvey Checkoway. Parkinsonism Relat Disord 2006
13
Diabetes mellitus and Parkinson disease.
Gennaro Pagano, Sotirios Polychronis, Heather Wilson, Beniamino Giordano, Nicola Ferrara, Flavia Niccolini, Marios Politis. Neurology 2018
Gennaro Pagano, Sotirios Polychronis, Heather Wilson, Beniamino Giordano, Nicola Ferrara, Flavia Niccolini, Marios Politis. Neurology 2018
13
Type 2 Diabetes as a Determinant of Parkinson's Disease Risk and Progression.
Harneek Chohan, Konstantin Senkevich, Radhika K Patel, Jonathan P Bestwick, Benjamin M Jacobs, Sara Bandres Ciga, Ziv Gan-Or, Alastair J Noyce. Mov Disord 2021
Harneek Chohan, Konstantin Senkevich, Radhika K Patel, Jonathan P Bestwick, Benjamin M Jacobs, Sara Bandres Ciga, Ziv Gan-Or, Alastair J Noyce. Mov Disord 2021
15
The epidemiology of Parkinson's disease: risk factors and prevention.
Alberto Ascherio, Michael A Schwarzschild. Lancet Neurol 2016
Alberto Ascherio, Michael A Schwarzschild. Lancet Neurol 2016
13
Hypertension, hypercholesterolemia, diabetes, and risk of Parkinson disease.
Kelly Claire Simon, Honglei Chen, Michael Schwarzschild, Alberto Ascherio. Neurology 2007
Kelly Claire Simon, Honglei Chen, Michael Schwarzschild, Alberto Ascherio. Neurology 2007
13
Diabetes and parkinsonian signs in older persons.
Zoe Arvanitakis, Robert S Wilson, Julia L Bienias, David A Bennett. Alzheimer Dis Assoc Disord 2007
Zoe Arvanitakis, Robert S Wilson, Julia L Bienias, David A Bennett. Alzheimer Dis Assoc Disord 2007
9
Neuroinflammation in Parkinson's disease: is there sufficient evidence for mechanism-based interventional therapy?
Malú G Tansey, Tamy C Frank-Cannon, Melissa K McCoy, Jae Kyung Lee, Terina N Martinez, Fiona E McAlpine, Kelly A Ruhn, Thi A Tran. Front Biosci 2008
Malú G Tansey, Tamy C Frank-Cannon, Melissa K McCoy, Jae Kyung Lee, Terina N Martinez, Fiona E McAlpine, Kelly A Ruhn, Thi A Tran. Front Biosci 2008
9
Cohort profile: the National Health Insurance Service-National Health Screening Cohort (NHIS-HEALS) in Korea.
Sang Cheol Seong, Yeon-Yong Kim, Sue K Park, Young Ho Khang, Hyeon Chang Kim, Jong Heon Park, Hee-Jin Kang, Cheol-Ho Do, Jong-Sun Song, Eun-Joo Lee,[...]. BMJ Open 2017
Sang Cheol Seong, Yeon-Yong Kim, Sue K Park, Young Ho Khang, Hyeon Chang Kim, Jong Heon Park, Hee-Jin Kang, Cheol-Ho Do, Jong-Sun Song, Eun-Joo Lee,[...]. BMJ Open 2017
9
Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.